Company / Current Assets per Share
ROCKET PHARMACEUTICALS, INC. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.81
FY2025
5-year range
$1.81 / $6.43
FY2021-FY2025
Trend
-56.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 5 consecutive years, from $8.90 in FY2020 to $1.81 in FY2025.
Based on SEC 10-K filings.
1.81 in FY2025 with a 5-year CAGR of -27.3%.
Declined from $4.78 to $1.81 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -31.5%
- 5-Year CAGR
- -27.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- ROCKET PHARMACEUTICALS, INC.'s current assets per share has declined for 5 consecutive years.
- In FY2025, current assets per share decreased 56.8% year-over-year.
- Peak current assets per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.81 | -56.8% |
| FY2024 | $4.19 | -12.4% |
| FY2023 | $4.78 | -15.3% |
| FY2022 | $5.64 | -12.2% |
| FY2021 | $6.43 | -27.8% |
| FY2020 | $8.90 | +30.5% |
| FY2019 | $6.82 | -77.8% |
| FY2018 | $30.77 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026